Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.689 | 2.277 | 0.64335 | 1.00000 | |
RegionR2 | 0.342 | 2.277 | 0.74405 | 1.00000 | |
RegionR3 | -1.853 | 2.277 | 0.99861 | 1.00000 | |
RegionR4 | -1.598 | 2.277 | 0.99815 | 1.00000 | |
RegionR5 | -0.965 | 2.277 | 0.98560 | 1.00000 | |
RegionR6 | -1.899 | 2.277 | 0.99882 | 1.00000 | |
RegionR7 | 3.686 | 2.277 | 0.00035 | 0.01522 | |
RegionR8 | 4.975 | 2.277 | 0.00000 | 0.00049 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.991 | 2.277 | 0.99984 | 1.00000 | |
RegenerationR2 | 1.265 | 2.277 | 0.25650 | 0.70282 | |
RegenerationR3 | 0.431 | 2.277 | 0.76074 | 0.96788 | |
RegenerationR4 | -0.18 | 2.277 | 0.96789 | 1.00000 | |
RegenerationR5 | -1.259 | 2.277 | 0.35741 | 0.76929 | |
RegenerationR6 | 0.811 | 2.277 | 0.58162 | 0.85845 | |
RegenerationBL | 0.231 | 2.277 | 0.82352 | 1.00000 | |
RegenerationTP | -1.057 | 2.277 | 0.35752 | 0.79833 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_14600 | 206 | 4.29 | Mlig455_038122, Mlig455_039790 | Neo: - Age: - Region-enriched R8: 4.975/0.00049 |
IGFALS | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_038122 {REF} {Length: 2842} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=8e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=136, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=95.9, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} Mlig455_039790 {REF} {Length: 2820} {Pfam: Leucine rich repeat [PF13855.8, score=265.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=153.7]; Leucine-rich repeat [PF14580.8, score=67.1]; BspA type Leucine rich repeat region (6 copies) [PF13306.8, score=59.8]; Leucine Rich Repeat [PF00560.35, score=56.6]; Leucine Rich repeat [PF13516.8, score=43.5]} {Human: ENSG00000099769, IGFALS, insulin like growth factor binding protein acid labile subunit, [Score=156, Expect=3e-39]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [RH, Score=160, Expect=7e-41]} {Dmel: FBgn0261269, conv, convoluted, [RH, Score=135, Expect=2e-32]} {Celegans: WBGene00016974, lron-15, ELRR (Extracellular Leucine-Rich Repeat) ONly, [RH, Score=149, Expect=1e-36]} {Smed: dd_Smed_v6_2769_0_1, dd_Smed_v6_2769_0_1, [RH, Score=96.3, Expect=2e-20]} {RNA1310_36223} {RNA815_24524} |
2. | MligTC455_24861 | 117 | 2.44 | Mlig455_019572 | Neo: - Age: - Region-enriched R8: 4.245/0.00630 |
FREM1 | 3.446 | 0.926 | - | - | 0.719 | 0.841 | 0.960 | Mlig455_019572 {REF} {Length: 8695} {Pfam: Cadherin-like [PF16184.7, score=328.8]; Frem protein N-terminal domain [PF19309.1, score=92.3]; Lectin C-type domain [PF00059.23, score=31.6]} {Human: ENSG00000164946, FREM1, FRAS1 related extracellular matrix 1, [RH, Score=370, Expect=2e-102]} {Mouse: ENSMUSG00000059049, Frem1, Fras1 related extracellular matrix protein 1, [RH, Score=381, Expect=3e-106]} {Smed: dd_Smed_v6_5187_0_1, dd_Smed_v6_5187_0_1, [RH, Score=508, Expect=4e-147]} {RNA1509_8234} {RNA1310_595.1} {RNA815_322} |
3. | MligTC455_33925 | 519 | 10.82 | Mlig455_020716, Mlig455_020784 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.564/0.00000 |
3.404 | 0.972 | 0.795 | - | - | 0.842 | 0.795 | Mlig455_020716 {REF} {Length: 1635} {Pfam: Amastin surface glycoprotein [PF07344.13, score=21.1]} {RNA1310_25321} {RNA815_36976} Mlig455_020784 {REF} {Length: 2274} {Pfam: Amastin surface glycoprotein [PF07344.13, score=22.1]} {RNA1310_25321} {RNA815_36976} |
|
4. | MligTC455_38796 | 1266 | 26.37 | Mlig455_060220, Mlig455_060235 | Neo: - Age: Down-Down-Up Region-enriched R8: 6.521/0.00003 |
BACE1 | 2.767 | 0.972 | 0.968 | - | - | - | 0.827 | Mlig455_060220 {REF} {Length: 1841} {Pfam: Eukaryotic aspartyl protease [PF00026.25, score=72.8]; Xylanase inhibitor C-terminal [PF14541.8, score=19.9]} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=215, Expect=3e-63]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=214, Expect=5e-63]} {Dmel: FBgn0032304, CG17134, [Score=56.2, Expect=3e-08]} {Celegans: WBGene00000218, asp-5, ASpartyl Protease, [Score=47.8, Expect=1e-05]} {RNA1509_48153} {RNA1310_17192, RNA1509_48153} {RNA1509_48153, RNA815_50706} Mlig455_060235 {REF} {Length: 1482} {Human: ENSG00000186318, BACE1, beta-secretase 1, [Score=119, Expect=2e-29]} {Mouse: ENSMUSG00000032086, Bace1, beta-site APP cleaving enzyme 1, [Score=118, Expect=1e-28]} {RNA1509_48153} {RNA1310_17192} {RNA815_51940} |
5. | MligTC455_25359 | 89 | 1.85 | Mlig455_026764, Mlig455_051780 | Neo: - Age: - |
2.733 | - | - | 0.966 | 0.823 | - | 0.944 | Mlig455_026764 {REF} {Length: 465} {RNA1310_85091} Mlig455_051780 {REF} {Length: 1387} {RNA1310_85091} {RNA815_62404} |
|
6. | MligTC455_41389 | 111 | 2.31 | Mlig455_024385 | Neo: - Age: - |
2.718 | - | - | 0.889 | 0.843 | - | 0.986 | Mlig455_024385 {REF} {Length: 569} {NoTransDecoderORF} {RNA1509_15591} {RNA1310_81202.1} {RNA815_31796} | |
7. | MligTC455_38303 | 142 | 2.96 | Mlig455_021803 | Neo: - Age: Up-Down-Down |
PCLO | 2.678 | 0.963 | - | - | 0.883 | - | 0.832 | Mlig455_021803 {REF} {Length: 6090} {Pfam: C2 domain [PF00168.32, score=66.7]; FYVE-type zinc finger [PF02318.18, score=55.2]; Piccolo Zn-finger [PF05715.15, score=27.5]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [RH, Score=122, Expect=6e-27]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=119, Expect=2e-26]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [Score=83.2, Expect=1e-15]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=1e-14]} {Smed: dd_Smed_v6_9615_0_1, dd_Smed_v6_9615_0_1, [RH, Score=185, Expect=4e-47]} {RNA1509_42665} {RNA1310_6999} {RNA815_17846} |
8. | MligTC455_25854 | 1015 | 21.15 | Mlig455_052672 | Neo: - Age: logFC(26M/2M)=-0.640 Region-specific R8: 3.800 Region-enriched R8: 3.703/0.00000 Regeneration-downregulated BL: -2.563 Regeneration-depleted BL: -2.563 |
2.62 | 0.954 | 0.837 | - | - | - | 0.829 | Mlig455_052672 {REF} {Length: 1364} {Pfam: PLAC8 family [PF04749.19, score=60.9]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=98.2, Expect=1e-26]} {RNA1509_58157} {RNA1310_24348, RNA1509_58157} {RNA1509_58157, RNA815_10637.1} | |
9. | MligTC455_37269 | 173 | 3.61 | Mlig455_020047 | Neo: - Age: - |
CASP3 | 1.897 | 0.958 | - | - | - | - | 0.939 | Mlig455_020047 {REF} {Length: 2828} {Pfam: Caspase domain [PF00656.24, score=94.7]; Ankyrin repeats (3 copies) [PF12796.9, score=79.1]; Ankyrin repeats (many copies) [PF13857.8, score=62.0]; Ankyrin repeats (many copies) [PF13637.8, score=58.0]; Ankyrin repeat [PF13606.8, score=40.7]; Ankyrin repeat [PF00023.32, score=31.7]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=111, Expect=1e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]} {Mouse: ENSMUSG00000031628, Casp3, caspase 3, [Score=106, Expect=5e-25]; ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=7e-25]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=2e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_10883_0_1, dd_Smed_v6_10883_0_1, [Score=107, Expect=1e-24]} {RNA1509_54818} {RNA1310_7187} {RNA815_8712} |
10. | MligTC455_36679 | 4666 | 97.21 | Mlig455_049598 | Neo: - Age: logFC(26M/2M)=-0.429 Region-enriched R8: 3.151/0.00004 |
1.887 | - | - | - | - | 0.965 | 0.922 | Mlig455_049598 {REF} {Length: 1229} {RNA1509_20268, RNA1509_24976} {RNA1310_46724, RNA1509_24976} {RNA1509_24976, RNA815_46768} | |
11. | MligTC455_56181 | 29 | 0.6 | Mlig455_020088 | Neo: - Age: - |
1.88 | - | - | 0.957 | - | - | 0.923 | Mlig455_020088 {REF} {Length: 619} {NoTransDecoderORF} {RNA1310_136270} | |
12. | MligTC455_51066 | 526 | 10.97 | Mlig455_044665, Mlig455_044724 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.381/0.00000 |
1.878 | - | - | - | 0.900 | - | 0.978 | Mlig455_044665 {REF} {Length: 1268} {Smed: dd_Smed_v6_7581_0_1, dd_Smed_v6_7581_0_1, [Score=148, Expect=3e-41]} {RNA1310_47069.2} {RNA815_30975} Mlig455_044724 {REF} {Length: 1327} {Smed: dd_Smed_v6_7581_0_1, dd_Smed_v6_7581_0_1, [Score=148, Expect=3e-41]} {RNA1310_47069.2} {RNA815_30975} |
|
13. | MligTC455_10178 | 77 | 1.6 | Mlig455_017978 | Neo: - Age: - Region-enriched R7: 6.377/0.00000 |
GRM3 | 1.87 | - | - | - | - | 0.912 | 0.958 | Mlig455_017978 {REF} {Length: 3464} {Pfam: Receptor family ligand binding region [PF01094.30, score=224.4]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=185.8]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=39.1]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [RH, Score=675, Expect=0.0]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [RH, Score=670, Expect=0.0]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=725, Expect=0.0]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [RH, Score=625, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [RH, Score=803, Expect=0.0]} {RNA1310_41220} |
14. | MligTC455_51640 | 166 | 3.46 | Mlig455_051173, Mlig455_062980 | Neo: - Age: - |
1.837 | - | - | - | 0.961 | - | 0.876 | Mlig455_051173 {REF} {Length: 1474} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=40.6]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=18.3]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=81.6, Expect=2e-17]} {RNA1310_26804} {RNA815_17702} Mlig455_062980 {REF} {Length: 2554} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=40.6]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=18.1]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=81.3, Expect=2e-17]} {RNA1310_26804} {RNA815_17702} |
|
15. | MligTC455_14869 | 56 | 1.17 | Mlig455_041087 | Neo: - Age: - |
1.834 | 0.876 | - | - | - | - | 0.958 | Mlig455_041087 {REF} {Length: 1408} {RNA1310_35281} {RNA815_59011} | |
16. | MligTC455_54350 | 200 | 4.17 | Mlig455_008866 | Neo: - Age: - |
PLAC8 | 1.833 | 0.876 | - | - | - | - | 0.957 | Mlig455_008866 {REF} {Length: 1137} {Pfam: PLAC8 family [PF04749.19, score=73.9]} {Human: ENSG00000145287, PLAC8, placenta specific 8, [Score=53.1, Expect=7e-10]} {Smed: dd_Smed_v6_477_0_1, dd_Smed_v6_477_0_1, [RH, Score=127, Expect=2e-39]} {RNA1509_49668} {RNA1310_34433, RNA1509_49668} {RNA1509_49668, RNA815_23736} |
17. | MligTC455_10719 | 61 | 1.26 | Mlig455_041088 | Neo: - Age: - |
1.831 | 0.861 | - | - | - | - | 0.970 | Mlig455_041088 {REF} {Length: 338} {NoTransDecoderORF} {RNA1310_18998} | |
18. | MligTC455_14375 | 163 | 3.4 | Mlig455_056945 | Neo: - Age: - |
1.805 | 0.975 | - | - | - | - | 0.830 | Mlig455_056945 {REF} {Length: 1764} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=49.6]} {Smed: dd_Smed_v6_32358_0_1, dd_Smed_v6_32358_0_1, [Score=94.4, Expect=4e-22]} {RNA1509_48719} {RNA1310_16266.1} {RNA815_10544.2} | |
19. | MligTC455_36215 | 359 | 7.47 | Mlig455_060878 | Neo: - Age: - Region-enriched R8: 8.367/0.00000 |
PLG | 1.802 | - | 0.974 | - | - | - | 0.828 | Mlig455_060878 {REF} {Length: 5184} {Pfam: Kringle domain [PF00051.20, score=232.3]} {Human: ENSG00000122194, PLG, plasminogen, [Score=147, Expect=7e-36]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=157, Expect=3e-39]} {Dmel: FBgn0020391, Nrk, Neurospecific receptor kinase, [Score=67.0, Expect=6e-11]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=66.2, Expect=7e-11]} {Smed: dd_Smed_v6_9220_0_1, dd_Smed_v6_9220_0_1, [RH, Score=247, Expect=5e-68]} {RNA1509_32537} {RNA1310_4321.1} {RNA815_8153} |
20. | MligTC455_03038 | 227 | 4.72 | Mlig455_060778 | Neo: - Age: Down-Up-Down Region-enriched R8: 6.261/0.00000 |
1.797 | 0.968 | - | - | - | - | 0.829 | Mlig455_060778 {REF} {Length: 4155} {TRANSSPLICED} {tRNA: Val(CAC),pseudo, score=27.8} {Mouse: ENSMUSG00000059854, Hydin, HYDIN, axonemal central pair apparatus protein, [Score=55.1, Expect=5e-07]} {RNA1509_16236} {RNA1310_4008} {RNA815_2550} | |
21. | MligTC455_43349 | 45 | 0.95 | Mlig455_025997, Mlig455_070422 | Neo: - Age: - |
1.793 | - | - | 0.951 | - | - | 0.842 | Mlig455_025997 {REF} {Length: 2086} {RNA1310_109338} Mlig455_070422 {REF} {Length: 2187} {RNA1310_109338} |
|
22. | MligTC455_13018 | 1993 | 41.51 | Mlig455_033923 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.482 Region-enriched R8: 5.842/0.00000 |
1.791 | 0.969 | - | - | - | - | 0.822 | Mlig455_033923 {REF} {Length: 1258} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1310_45334, RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130} {RNA1509_17580, RNA1509_20381, RNA1509_25516, RNA1509_52130, RNA815_5573.2} | |
23. | MligTC455_33475 | 168 | 3.5 | Mlig455_036879 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.551 Region-enriched R8: 7.210/0.00005 |
1.79 | 0.974 | - | - | - | - | 0.816 | Mlig455_036879 {REF} {Length: 2954} {RNA1509_20567} {RNA1310_1034.1} {RNA815_502.1} | |
24. | MligTC455_21451 | 352 | 7.34 | Mlig455_040118, Mlig455_067333 | Neo: - Age: - Region-enriched R8: 6.038/0.00000 |
ANGPTL7 | 1.782 | 0.957 | - | - | - | - | 0.825 | Mlig455_040118 {REF} {Length: 1728} {tRNA: Val(CAC),pseudo, score=20.9} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.6]; PAN domain [PF00024.28, score=20.2]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=98.6, Expect=3e-23]; ENSG00000120332, TNN, tenascin N, [Score=98.2, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=96.7, Expect=5e-22]; ENSG00000116147, TNR, tenascin R, [Score=96.7, Expect=8e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=94.0, Expect=5e-22]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=2e-22]; ENSMUSG00000015829, Tnr, tenascin R, [Score=97.8, Expect=2e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=95.9, Expect=5e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=2e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.0, Expect=8e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=9e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.2, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=100, Expect=8e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} Mlig455_067333 {REF} {Length: 1595} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=128.2]; PAN domain [PF00024.28, score=20.3]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=99.8, Expect=1e-23]; ENSG00000120332, TNN, tenascin N, [Score=99.0, Expect=2e-22]; ENSG00000171564, FGB, fibrinogen beta chain, [Score=98.2, Expect=2e-22]; ENSG00000116147, TNR, tenascin R, [Score=97.1, Expect=7e-22]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=98.2, Expect=2e-22]; ENSMUSG00000026725, Tnn, tenascin N, [Score=97.8, Expect=3e-22]; ENSMUSG00000033831, Fgb, fibrinogen beta chain, [Score=97.4, Expect=2e-22]; ENSMUSG00000026938, Fcna, ficolin A, [Score=95.5, Expect=3e-22]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=94.4, Expect=6e-22]} {Dmel: FBgn0050280, CG30280, [Score=111, Expect=8e-29]} {Celegans: WBGene00020516, T15B7.1, [Score=68.6, Expect=6e-13]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=101, Expect=4e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} |
25. | MligTC455_20781 | 5503 | 114.65 | Mlig455_066518 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.978 Region-enriched R8: 6.430/0.00000 |
FBN2 | 1.78 | 0.964 | - | - | - | - | 0.816 | Mlig455_066518 {REF} {Length: 6133} {Pfam: EGF domain [PF12947.9, score=539.9]; Calcium-binding EGF domain [PF07645.17, score=534.2]; Complement Clr-like EGF-like [PF12662.9, score=301.4]; EGF-like domain [PF00008.29, score=202.5]; Human growth factor-like EGF [PF12661.9, score=158.8]; MSP1 EGF domain 1 [PF12946.9, score=133.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=101.2]; Pvs28 EGF domain [PF06247.13, score=76.5]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=27.8]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=348, Expect=8e-98]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=350, Expect=2e-98]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-96]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=268, Expect=2e-72]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=426, Expect=1e-123]} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA1509_770} {RNA1310_1209, RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746} {RNA1509_12396, RNA1509_21908, RNA1509_41091, RNA1509_6746, RNA815_317.1} |
26. | MligTC455_40223 | 172 | 3.59 | Mlig455_016264 | Neo: - Age: - Region-enriched R8: 3.704/0.01076 |
CHRNA10 | 1.768 | 0.961 | - | - | - | - | 0.807 | Mlig455_016264 {REF} {Length: 4782} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=169.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=230, Expect=2e-68]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=225, Expect=1e-66]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=233, Expect=9e-70]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=236, Expect=2e-70]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=215, Expect=6e-63]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=280, Expect=9e-87]} {RNA1509_35668} {RNA1310_11720.1} {RNA815_6827} |
27. | MligTC455_44435 | 628 | 13.08 | Mlig455_062382, Mlig455_062409 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.421 Region-enriched R8: 5.635/0.00000 |
DDI2, HMCN1 | 1.766 | 0.975 | - | - | - | - | 0.791 | Mlig455_062382 {REF} {Length: 12544} {TRANSSPLICED} {Pfam: Aspartyl protease [PF09668.12, score=182.5]; gag-polyprotein putative aspartyl protease [PF13975.8, score=76.1]; Thrombospondin type 1 domain [PF00090.21, score=72.3]; Spondin-like TSP1 domain [PF19028.2, score=68.4]; Arginine repressor, C-terminal domain [PF02863.20, score=43.6]; Aspartyl protease [PF13650.8, score=34.4]; Putative vacuolating cytotoxin [PF03077.16, score=29.0]; Ubiquitin-2 like Rad60 SUMO-like [PF11976.10, score=26.1]; Thrombospondin type 1 domain [PF19030.2, score=23.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=22.2]; Retroviral aspartyl protease [PF00077.22, score=19.1]} {Human: ENSG00000197312, DDI2, DNA damage inducible 1 homolog 2, [Score=279, Expect=2e-82]} {Mouse: ENSMUSG00000078515, Ddi2, DNA-damage inducible protein 2, [Score=266, Expect=5e-78]; ENSMUSG00000047619, Ddi1, DNA-damage inducible 1, [Score=255, Expect=4e-74]} {Dmel: FBgn0030753, rngo, rings lost, [Score=275, Expect=1e-80]} {Celegans: WBGene00015308, ddi-1, Dna (DNA) Damage Inducible homolog, [Score=131, Expect=5e-32]} {Smed: dd_Smed_v6_2764_0_1, dd_Smed_v6_2764_0_1, [Score=213, Expect=1e-60]} {RNA1509_6950} {RNA1310_548} {RNA815_300} Mlig455_062409 {REF} {Length: 19342} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=78.9]; Thrombospondin type 1 domain [PF00090.21, score=74.6]; Arginine repressor, C-terminal domain [PF02863.20, score=41.0]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=40.0]; CCN3 Nov like TSP1 domain [PF19035.2, score=32.2]; Putative vacuolating cytotoxin [PF03077.16, score=30.3]; Thrombospondin type 1 domain [PF19030.2, score=23.2]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=90.1, Expect=7e-17]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=90.5, Expect=4e-17]} {Dmel: FBgn0050046, CG30046, [Score=52.4, Expect=8e-06]} {Celegans: WBGene00000083, adt-2, ADAMTS family; ADAMTS-like protease, [Score=87.8, Expect=1e-16]} {Smed: dd_Smed_v6_628_0_1, dd_Smed_v6_628_0_1, [Score=159, Expect=6e-39]} {RNA1509_21415, RNA1509_6950} {RNA1310_548, RNA1509_21415, RNA1509_6950} {RNA1509_21415, RNA1509_6950, RNA815_300} |
28. | MligTC455_39971 | 147 | 3.07 | Mlig455_034549 | Neo: - Age: - Region-enriched R8: 4.475/0.00030 |
1.743 | 0.977 | - | - | - | - | 0.766 | Mlig455_034549 {REF} {Length: 2181} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {RNA1310_27858} {RNA815_17949} | |
29. | MligTC455_20780 | 8892 | 185.26 | Mlig455_040314 | Neo: - Age: logFC(26M/2M)=-1.054 Region-enriched R8: 6.072/0.00000 |
NOTCH2 | 1.742 | 0.959 | - | - | - | - | 0.783 | Mlig455_040314 {REF} {Length: 15786} {Pfam: EGF domain [PF12947.9, score=500.6]; Calcium-binding EGF domain [PF07645.17, score=489.8]; Complement Clr-like EGF-like [PF12662.9, score=268.7]; EGF-like domain [PF00008.29, score=175.9]; Human growth factor-like EGF [PF12661.9, score=135.4]; MSP1 EGF domain 1 [PF12946.9, score=91.5]; von Willebrand factor type D domain [PF00094.27, score=75.8]; Coagulation Factor Xa inhibitory site [PF14670.8, score=51.8]; Pvs28 EGF domain [PF06247.13, score=34.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=25.7]} {Human: ENSG00000134250, NOTCH2, notch 2, [Score=246, Expect=4e-64]; ENSG00000138829, FBN2, fibrillin 2, [Score=237, Expect=3e-61]} {Mouse: ENSMUSG00000027878, Notch2, notch 2, [Score=249, Expect=6e-65]} {Dmel: FBgn0053196, dpy, dumpy, [Score=343, Expect=2e-93]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [RH, Score=254, Expect=5e-67]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=415, Expect=3e-115]} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_770, RNA1509_9237} {RNA1310_1209, RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237} {RNA1509_11248, RNA1509_12416, RNA1509_21118, RNA1509_37363, RNA1509_39736, RNA1509_45308, RNA1509_5454, RNA1509_57584, RNA1509_59762, RNA1509_9237, RNA815_317.1} |
30. | MligTC455_07961 | 191 | 3.98 | Mlig455_051526 | Neo: - Age: - Region-enriched R8: 7.862/0.00000 Regeneration-enriched R5: 7.080 |
1.73 | 0.970 | - | - | - | - | 0.760 | Mlig455_051526 {REF} {Length: 437} {RNA815_63444} | |
31. | MligTC455_30986 | 631 | 13.14 | Mlig455_010831, Mlig455_033221 | Neo: - Age: - Region-enriched R7: 2.524/0.00004 Regeneration-downregulated BL: -6.030 Regeneration-depleted BL: -6.030 |
PITPNC1 | 1.727 | 0.973 | - | - | - | 0.754 | - | Mlig455_010831 {REF} {Length: 1024} {Pfam: Phosphatidylinositol transfer protein [PF02121.20, score=91.8]} {Human: ENSG00000154217, PITPNC1, phosphatidylinositol transfer protein cytoplasmic 1, [Score=88.6, Expect=3e-21]} {Mouse: ENSMUSG00000040430, Pitpnc1, phosphatidylinositol transfer protein, cytoplasmic 1, [Score=89.0, Expect=1e-21]} {Dmel: FBgn0027872, rdgBbeta, [Score=91.3, Expect=2e-22]} {Celegans: WBGene00010813, pitp-1, PhosphatidylInositol Transfer Protein family, [Score=71.2, Expect=8e-15]} {Smed: dd_Smed_v6_580_0_1, dd_Smed_v6_580_0_1, [Score=65.9, Expect=2e-13]} {RNA1509_38619} {RNA1310_18833} {RNA815_8161} Mlig455_033221 {REF} {Length: 1640} {Pfam: Phosphatidylinositol transfer protein [PF02121.20, score=237.1]} {Human: ENSG00000154217, PITPNC1, phosphatidylinositol transfer protein cytoplasmic 1, [Score=144, Expect=4e-39]} {Mouse: ENSMUSG00000040430, Pitpnc1, phosphatidylinositol transfer protein, cytoplasmic 1, [Score=145, Expect=6e-40]} {Dmel: FBgn0027872, rdgBbeta, [Score=134, Expect=1e-35]} {Celegans: WBGene00010813, pitp-1, PhosphatidylInositol Transfer Protein family, [Score=111, Expect=1e-25]} {Smed: dd_Smed_v6_7211_0_2, dd_Smed_v6_7211_0_2, [Score=114, Expect=6e-27]} {RNA1509_38619} {RNA1310_18833} {RNA815_8161} |
32. | MligTC455_15755 | 62 | 1.3 | Mlig455_051284 | Neo: - Age: - Region-enriched R7: 4.959/0.00065 |
CHRNB3 | 1.725 | 0.762 | - | - | - | - | 0.963 | Mlig455_051284 {REF} {Length: 2666} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=130.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=32.4]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=142, Expect=1e-37]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=139, Expect=2e-36]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=137, Expect=1e-35]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=160, Expect=5e-44]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=146, Expect=9e-39]} {Celegans: WBGene00020048, lgc-12, Ligand-Gated ion Channel, [Score=140, Expect=2e-37]} {Smed: dd_Smed_v6_29533_0_1, dd_Smed_v6_29533_0_1, [RH, Score=205, Expect=1e-61]} {RNA1310_22037} {RNA815_37244} |
33. | MligTC455_48302 | 45 | 0.93 | Mlig455_056275 | Neo: - Age: - |
CHRNA7 | 1.724 | - | - | - | - | 0.741 | 0.983 | Mlig455_056275 {REF} {Length: 3506} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=176.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=131.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=255, Expect=4e-76]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=251, Expect=5e-75]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=250, Expect=2e-74]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=245, Expect=6e-73]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=237, Expect=7e-70]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=234, Expect=6e-69]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=271, Expect=1e-82]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=254, Expect=1e-76]} {Smed: dd_Smed_v6_18201_0_1, dd_Smed_v6_18201_0_1, [Score=471, Expect=8e-158]} {RNA1509_49660} {RNA1310_35095} {RNA815_30373} |
34. | MligTC455_40058 | 236 | 4.92 | Mlig455_024609, Mlig455_047564, Mlig455_048256, Mlig455_048290 | Neo: - Age: Up-Down-Down Region-enriched R8: 4.442/0.00145 |
1.723 | - | 0.973 | - | - | 0.750 | - | Mlig455_024609 {REF} {Length: 2945} {Pfam: Zinc knuckle [PF00098.25, score=31.5]; GAG-polyprotein viral zinc-finger [PF14787.8, score=18.6]} {RNA1509_14379, RNA1509_19573, RNA1509_32874} {RNA1310_13252, RNA1509_14379, RNA1509_19573, RNA1509_32874} {RNA1509_14379, RNA1509_19573, RNA1509_32874, RNA815_318.1} Mlig455_047564 {REF} {Length: 1201} {Pfam: Zinc knuckle [PF00098.25, score=31.5]; GAG-polyprotein viral zinc-finger [PF14787.8, score=18.6]} {RNA1509_14379} {RNA1310_13252} {RNA815_318.1} Mlig455_048256 {REF} {Length: 2929} {Pfam: Zinc knuckle [PF00098.25, score=31.5]; GAG-polyprotein viral zinc-finger [PF14787.8, score=18.6]} {RNA1509_19573} {RNA1310_13252} {RNA815_318.1} Mlig455_048290 {REF} {Length: 2908} {Pfam: Zinc knuckle [PF00098.25, score=31.5]; GAG-polyprotein viral zinc-finger [PF14787.8, score=18.6]} {RNA1509_19573} {RNA1310_13252} {RNA815_318.1} |
|
35. | MligTC455_53279 | 2935 | 61.14 | Mlig455_017965 | Neo: - Age: Down-Up-Down Region-specific R8: 3.606 Region-enriched R8: 3.165/0.00000 Regeneration-downregulated BL: -2.902 Regeneration-depleted BL: -2.902 |
1.723 | 0.968 | - | - | - | - | 0.755 | Mlig455_017965 {REF} {Length: 1023} {RNA1509_20769, RNA1509_34269} {RNA1310_44808, RNA1509_20769, RNA1509_34269} {RNA1509_20769, RNA1509_34269, RNA815_8213} | |
36. | MligTC455_39972 | 142 | 2.96 | Mlig455_064814 | Neo: - Age: - Region-enriched R8: 4.539/0.00054 |
1.713 | 0.977 | - | - | - | - | 0.736 | Mlig455_064814 {REF} {Length: 2232} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=34.6]} {RNA1310_27858} {RNA815_17949} | |
37. | MligTC455_36963 | 39 | 0.81 | Mlig455_050201 | Neo: - Age: Up-Down-Down |
AVPR1B | 1.701 | 0.737 | - | - | - | - | 0.964 | Mlig455_050201 {REF} {Length: 2792} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=152.5]; Olfactory receptor [PF13853.8, score=29.2]} {Human: ENSG00000198049, AVPR1B, arginine vasopressin receptor 1B, [Score=92.8, Expect=1e-19]} {Mouse: ENSMUSG00000049112, Oxtr, oxytocin receptor, [Score=94.0, Expect=3e-20]} {Dmel: FBgn0025595, AkhR, Adipokinetic hormone receptor, [Score=80.5, Expect=7e-16]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=79.0, Expect=3e-15]} {Smed: dd_Smed_v6_45004_0_1, dd_Smed_v6_45004_0_1, [Score=69.7, Expect=8e-13]} {RNA1310_72444} {RNA815_35126} |
38. | MligTC455_45987 | 1592 | 33.17 | Mlig455_024379, Mlig455_024495 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.664 Region-specific R8: 3.405 Region-enriched R8: 3.716/0.00000 Regeneration-depleted BL: -2.612 |
PKDREJ | 1.698 | 0.956 | - | - | - | - | 0.742 | Mlig455_024379 {REF} {Length: 9101} {Pfam: PKD domain [PF18911.2, score=34.9]; PKD domain [PF00801.22, score=21.5]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} Mlig455_024495 {REF} {Length: 8484} {Pfam: Polycystin cation channel [PF08016.14, score=333.9]; PLAT/LH2 domain [PF01477.25, score=69.5]; PKD domain [PF18911.2, score=32.8]; Ion transport protein [PF00520.33, score=31.6]; PKD domain [PF00801.22, score=19.8]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [RH, Score=346, Expect=8e-95]} {Mouse: ENSMUSG00000052496, Pkdrej, polycystin (PKD) family receptor for egg jelly, [RH, Score=327, Expect=4e-89]; ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [RH, Score=319, Expect=7e-87]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=167, Expect=3e-41]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=198, Expect=3e-52]} {Smed: dd_Smed_v6_10962_0_1, dd_Smed_v6_10962_0_1, [Score=592, Expect=9e-172]} {RNA1509_1257} {RNA1310_126.1} {RNA815_58} |
39. | MligTC455_47905 | 56 | 1.16 | Mlig455_037694 | Neo: - Age: - |
1.691 | 0.963 | - | - | 0.728 | - | - | Mlig455_037694 {REF} {Length: 2503} {RNA1310_36768.1} {RNA815_27683} | |
40. | MligTC455_30985 | 442 | 9.22 | Mlig455_010824 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.207/0.00023 Regeneration-downregulated BL: -3.092 Regeneration-depleted BL: -3.092 |
1.673 | 0.965 | - | - | - | 0.708 | - | Mlig455_010824 {REF} {Length: 2717} {Pfam: Pao retrotransposon peptidase [PF05380.15, score=178.4]; Family of unknown function (DUF5641) [PF18701.3, score=106.4]; Integrase zinc binding domain [PF17921.3, score=34.3]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=32.6]} {Celegans: WBGene00044435, Y20F4.8, [Score=64.7, Expect=9e-11]} {Smed: dd_Smed_v6_22202_0_1, dd_Smed_v6_22202_0_1, [RH, Score=119, Expect=5e-31]} {RNA1509_9219} {RNA1310_468} {RNA815_355.1} | |
41. | MligTC455_41805 | 2256 | 47 | Mlig455_015764, Mlig455_049489 | Neo: - Age: - Region-specific R8: 2.792 Region-enriched R8: 2.927/0.00000 |
PKD2 | 1.669 | 0.964 | - | - | - | - | 0.705 | Mlig455_015764 {REF} {Length: 3347} {Pfam: Polycystin cation channel [PF08016.14, score=395.7]; Ion transport protein [PF00520.33, score=60.8]; EF hand [PF00036.34, score=22.8]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [Score=618, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [Score=617, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=255, Expect=3e-72]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=338, Expect=2e-104]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=660, Expect=0.0]} {RNA1509_31010} {RNA1310_4653.2} {RNA815_18688} Mlig455_049489 {REF} {Length: 3379} {Pfam: Polycystin cation channel [PF08016.14, score=493.3]; Ion transport protein [PF00520.33, score=89.5]; EF hand [PF00036.34, score=27.1]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=20.9]; EF-hand domain [PF13405.8, score=18.5]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=716, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=711, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=306, Expect=1e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=739, Expect=0.0]} {RNA1509_31010, RNA1509_51627} {RNA1310_4653.1, RNA1509_31010, RNA1509_51627} {RNA1509_31010, RNA1509_51627, RNA815_4316} |
42. | MligTC455_17187 | 85 | 1.77 | Mlig455_040722 | Neo: - Age: logFC(26M/2M)=-0.644 |
SCNN1B | 0.988 | - | - | - | - | - | 0.988 | Mlig455_040722 {REF} {Length: 2368} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.4]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=64.3, Expect=5e-10]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_25838_0_1, dd_Smed_v6_25838_0_1, [Score=230, Expect=3e-67]} {RNA1509_57515} {RNA1310_24808, RNA1509_57515} {RNA1509_57515, RNA815_46525} |
43. | MligTC455_10024 | 48 | 0.99 | Mlig455_065062 | Neo: - Age: - |
0.986 | - | - | - | - | - | 0.986 | Mlig455_065062 {REF} {Length: 3160} {RNA1310_7348} {RNA815_14995} | |
44. | MligTC455_15886 | 18 | 0.38 | Mlig455_004437 | Neo: - Age: - |
0.984 | - | - | 0.984 | - | - | - | Mlig455_004437 {REF} {Length: 784} | |
45. | MligTC455_13060 | 99 | 2.06 | Mlig455_022766 | Neo: - Age: - |
0.982 | - | - | - | - | - | 0.982 | Mlig455_022766 {REF} {Length: 787} {NoTransDecoderORF} {RNA1310_132565} | |
46. | MligTC455_18569 | 79 | 1.65 | Mlig455_002173, Mlig455_002274, Mlig455_002318 | Neo: - Age: - Region-enriched R4: 6.510/0.00058 |
0.982 | - | - | - | - | - | 0.982 | Mlig455_002173 {REF} {Length: 1129} {NoTransDecoderORF} {RNA1509_52353} {RNA1310_130608} {RNA815_60304} Mlig455_002274 {REF} {Length: 1130} {NoTransDecoderORF} {RNA1509_52353} {RNA1310_130608} {RNA815_60304} Mlig455_002318 {REF} {Length: 1012} {NoTransDecoderORF} {RNA1509_52353} {RNA1310_130608} {RNA815_60304} |
|
47. | MligTC455_21657 | 84 | 1.76 | Mlig455_048610 | Neo: - Age: - |
LMO1 | 0.981 | 0.981 | - | - | - | - | - | Mlig455_048610 {REF} {Length: 2071} {Pfam: LIM domain [PF00412.24, score=90.0]} {Human: ENSG00000166407, LMO1, LIM domain only 1, [RH, Score=186, Expect=1e-60]; ENSG00000048540, LMO3, LIM domain only 3, [RH, Score=183, Expect=2e-59]} {Mouse: ENSMUSG00000036111, Lmo1, LIM domain only 1, [RH, Score=183, Expect=1e-59]; ENSMUSG00000030226, Lmo3, LIM domain only 3, [RH, Score=183, Expect=1e-59]} {Dmel: FBgn0265598, Bx, Beadex, [RH, Score=198, Expect=1e-62]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=79.3, Expect=7e-18]} {Smed: dd_Smed_v6_17422_0_1, dd_Smed_v6_17422_0_1, [RH, Score=140, Expect=6e-42]} {RNA1310_56294} {RNA815_40845} |
48. | MligTC455_17526 | 31 | 0.65 | Mlig455_000396, Mlig455_067969 | Neo: - Age: - |
0.978 | - | - | 0.978 | - | - | - | Mlig455_000396 {REF} {Length: 432} {RNA1509_2497} {RNA1310_110686} {RNA815_7166} Mlig455_067969 {REF} {Length: 399} {RNA1509_2497} {RNA1310_110686} {RNA815_7166} |
|
49. | MligTC455_27763 | 38 | 0.79 | Mlig455_027014, Mlig455_027077 | Neo: - Age: - |
ASIC1 | 0.978 | - | - | - | - | - | 0.978 | Mlig455_027014 {REF} {Length: 2765} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=153.0]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=52.0, Expect=2e-06]} {Celegans: WBGene00006748, unc-8, Degenerin unc-8, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_8949_0_1, dd_Smed_v6_8949_0_1, [Score=94.0, Expect=6e-20]} {RNA1310_11972} {RNA815_48193} Mlig455_027077 {REF} {Length: 3006} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=211.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=59.7, Expect=1e-08]; ENSG00000108684, ASIC2, acid sensing ion channel subunit 2, [Score=58.2, Expect=4e-08]} {Mouse: ENSMUSG00000020704, Asic2, acid-sensing (proton-gated) ion channel 2, [Score=59.3, Expect=1e-08]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=56.6, Expect=8e-08]} {Celegans: WBGene00006748, unc-8, Degenerin unc-8, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_8949_0_1, dd_Smed_v6_8949_0_1, [Score=115, Expect=2e-26]} {RNA1310_11972} {RNA815_48193} |
50. | MligTC455_20782 | 91 | 1.9 | Mlig455_066519 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.321 Region-enriched R8: 5.950/0.00576 |
0.976 | 0.976 | - | - | - | - | - | Mlig455_066519 {REF} {Length: 3710} {RNA1509_53671} {RNA1310_35957.1} {RNA815_13121.1} | |
51. | MligTC455_38276 | 63 | 1.32 | Mlig455_029777 | Neo: - Age: logFC(26M/2M)=-0.514 |
TRPM7 | 0.976 | - | - | - | 0.976 | - | - | Mlig455_029777 {REF} {Length: 2544} {TRANSSPLICED} {Pfam: Alpha-kinase family [PF02816.20, score=42.3]} {Human: ENSG00000092439, TRPM7, transient receptor potential cation channel subfamily M member 7, [Score=49.7, Expect=1e-05]} {Mouse: ENSMUSG00000027365, Trpm7, transient receptor potential cation channel, subfamily M, member 7, [Score=49.7, Expect=9e-06]} {RNA1509_12880} {RNA1310_21325} {RNA815_6188} |
52. | MligTC455_10816 | 14 | 0.29 | Mlig455_027523, Mlig455_046082, Mlig455_061029 | Neo: - Age: - |
0.974 | - | - | - | - | - | 0.974 | Mlig455_027523 {REF} {Length: 383} {RNA1310_79750} Mlig455_046082 {REF} {Length: 352} Mlig455_061029 {REF} {Length: 475} {RNA1310_79750} |
|
53. | MligTC455_31527 | 139 | 2.9 | Mlig455_005639, Mlig455_016710, Mlig455_020437, Mlig455_057295, Mlig455_057296 | Neo: - |
SETMAR | 0.974 | - | - | - | - | - | 0.974 | Mlig455_005639 {REF} {Length: 536} {Pfam: Helix-turn-helix domain [PF13518.8, score=33.0]; Winged helix-turn helix [PF13551.8, score=25.1]; Homeodomain-like domain [PF13565.8, score=23.5]; Transposase [PF01710.18, score=22.0]; Transposase [PF01527.22, score=20.1]; Homeodomain-like domain [PF13384.8, score=18.6]; Helix-turn-helix domain of transposase family ISL3 [PF13542.8, score=18.0]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=47.4, Expect=4e-06]} {RNA1509_38400} {RNA1310_5895.2} {RNA815_1641.1} Mlig455_016710 {REF} {Length: 3859} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=31.7]; Helix-turn-helix domain [PF13518.8, score=28.1]; DDE superfamily endonuclease [PF13358.8, score=27.7]; Homeodomain-like domain [PF13565.8, score=21.8]; Transposase [PF01710.18, score=20.3]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=57.0, Expect=1e-07]} {Smed: dd_Smed_v6_16239_0_3, dd_Smed_v6_16239_0_3, [Score=55.1, Expect=2e-08]} {RNA1509_38400} {RNA1310_5895.2} {RNA815_1641.1} Mlig455_020437 {REF} {Length: 743} {Pfam: DDE superfamily endonuclease [PF13358.8, score=23.5]} {RNA1509_38400} {RNA1310_5895.2} {RNA815_1641.1} Mlig455_057295 {REF} {Length: 539} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=31.7]; Helix-turn-helix domain [PF13518.8, score=28.1]; DDE superfamily endonuclease [PF13358.8, score=27.7]; Homeodomain-like domain [PF13565.8, score=21.8]; Transposase [PF01710.18, score=20.3]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=57.0, Expect=1e-07]} {Smed: dd_Smed_v6_16239_0_3, dd_Smed_v6_16239_0_3, [Score=55.1, Expect=2e-08]} {RNA1509_38400} {RNA1310_5895.2} {RNA815_1641.1} Mlig455_057296 {REF} {Length: 506} {Pfam: Helix-turn-helix domain [PF13518.8, score=31.0]; DDE superfamily endonuclease [PF13358.8, score=30.3]; Winged helix-turn helix [PF13551.8, score=22.7]; Homeodomain-like domain [PF13565.8, score=22.2]; Transposase [PF01710.18, score=21.8]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=59.3, Expect=4e-09]} {Smed: dd_Smed_v6_16239_0_2, dd_Smed_v6_16239_0_2, [Score=57.8, Expect=5e-10]} {RNA1509_38400} {RNA1310_5895.2} {RNA815_1641.1} |
54. | MligTC455_51399 | 52 | 1.09 | Mlig455_051021 | Neo: - Age: Up-Down-Down |
KCNT1 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_051021 {REF} {Length: 4250} {Pfam: Calcium-activated BK potassium channel alpha subunit [PF03493.20, score=92.3]; Ion channel [PF07885.18, score=44.0]} {Human: ENSG00000107147, KCNT1, potassium sodium-activated channel subfamily T member 1, [Score=901, Expect=0.0]; ENSG00000162687, KCNT2, potassium sodium-activated channel subfamily T member 2, [Score=862, Expect=0.0]} {Mouse: ENSMUSG00000058740, Kcnt1, potassium channel, subfamily T, member 1, [Score=870, Expect=0.0]; ENSMUSG00000052726, Kcnt2, potassium channel, subfamily T, member 2, [Score=870, Expect=0.0]} {Dmel: FBgn0261698, SLO2, slowpoke 2, [RH, Score=818, Expect=0.0]} {Celegans: WBGene00004831, slo-2, SLO-2 potassium channel; SLOwpoke potassium channel family, [Score=666, Expect=0.0]} {Smed: dd_Smed_v6_9739_0_1, dd_Smed_v6_9739_0_1, [Score=1093, Expect=0.0]} {RNA1509_10851} {RNA1310_10826.1} {RNA815_3987} |
55. | MligTC455_41660 | 162 | 3.38 | Mlig455_054021 | Neo: - Age: - |
0.973 | - | - | - | - | - | 0.973 | Mlig455_054021 {REF} {Length: 441} {NoTransDecoderORF} {RNA1509_37967} {RNA1310_6299.1} {RNA815_1994.1} | |
56. | MligTC455_49364 | 19 | 0.4 | Mlig455_052869 | Neo: - Age: - |
0.972 | - | - | - | - | - | 0.972 | Mlig455_052869 {REF} {Length: 116} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_30132} {RNA1310_6179.1} {RNA815_3037} | |
57. | MligTC455_13917 | 50 | 1.05 | Mlig455_006935, Mlig455_017950 | Neo: - Age: - |
0.97 | - | - | - | - | - | 0.970 | Mlig455_006935 {REF} {Length: 1553} {RNA1310_24840} {RNA815_41829} Mlig455_017950 {REF} {Length: 1661} {RNA1310_24840} {RNA815_41829} |
|
58. | MligTC455_16918 | 1218 | 25.38 | Mlig455_039085, Mlig455_042780 | Neo: - Age: Up-Down-Down Region-enriched R8: 5.308/0.00000 |
MECOM | 0.97 | 0.970 | - | - | - | - | - | Mlig455_039085 {REF} {Length: 4916} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=99.3]; C2H2-type zinc finger [PF13894.8, score=76.6]; Zinc-finger double domain [PF13465.8, score=72.4]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=41.2]; C2H2-type zinc finger [PF13912.8, score=35.0]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=25.5]; Zinc-finger of C2H2 type [PF12874.9, score=20.9]; C2H2-type zinc-finger domain [PF13909.8, score=18.4]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=147, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=145, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=146, Expect=2e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=146, Expect=9e-35]} {Dmel: FBgn0045852, ham, hamlet, [RH, Score=149, Expect=1e-36]} {Celegans: WBGene00015646, mlt-10, [Score=172, Expect=3e-44]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=145, Expect=5e-38]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} Mlig455_042780 {REF} {Length: 3778} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.4]; Zinc-finger double domain [PF13465.8, score=59.4]; C2H2-type zinc finger [PF13894.8, score=36.4]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=29.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=29.0]; C2H2-type zinc finger [PF13912.8, score=28.6]; Zinc-finger of C2H2 type [PF12874.9, score=24.8]; C2H2-type zinc-finger domain [PF13909.8, score=21.2]; GAGA factor [PF09237.13, score=19.5]; C2H2 type zinc-finger (2 copies) [PF12756.9, score=18.9]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=6e-35]; ENSG00000142611, PRDM16, PR/SET domain 16, [RH, Score=139, Expect=3e-34]} {Mouse: ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [RH, Score=141, Expect=3e-35]; ENSMUSG00000039410, Prdm16, PR domain containing 16, [RH, Score=140, Expect=1e-34]} {Dmel: FBgn0032707, CG10348, [RH, Score=144, Expect=8e-37]} {Celegans: WBGene00001207, egl-43, Egl-43, [RH, Score=98.2, Expect=2e-22]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [RH, Score=144, Expect=9e-39]} {RNA1509_21422} {RNA1310_3577} {RNA815_16096} |
59. | MligTC455_19438 | 27 | 0.56 | Mlig455_016816 | Neo: - Age: - |
RXRA | 0.97 | - | - | - | - | - | 0.970 | Mlig455_016816 {REF} {Length: 1783} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=72.3]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=23.6]} {Human: ENSG00000186350, RXRA, retinoid X receptor alpha, [Score=82.0, Expect=2e-16]} {Mouse: ENSMUSG00000015846, Rxra, retinoid X receptor alpha, [Score=80.9, Expect=3e-16]; ENSMUSG00000024955, Esrra, estrogen related receptor, alpha, [Score=79.3, Expect=1e-15]; ENSMUSG00000015843, Rxrg, retinoid X receptor gamma, [Score=77.4, Expect=5e-15]} {Dmel: FBgn0003964, usp, ultraspiracle, [Score=75.5, Expect=2e-14]} {Celegans: WBGene00003651, nhr-61, Nuclear hormone receptor family member nhr-61, [Score=86.7, Expect=2e-18]} {Smed: dd_Smed_v6_3012_0_1, dd_Smed_v6_3012_0_1, [Score=79.0, Expect=1e-15]} {RNA1310_147040} |
60. | MligTC455_33966 | 34 | 0.72 | Mlig455_032703 | Neo: - Age: - |
0.97 | - | - | - | - | - | 0.970 | Mlig455_032703 {REF} {Length: 907} {Pfam: F5/8 type C domain [PF00754.27, score=32.8]} {Dmel: FBgn0001083, fw, furrowed, [Score=46.6, Expect=8e-06]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=53.1, Expect=4e-09]} {RNA1509_42117} {RNA1310_82261} {RNA815_54270} | |
61. | MligTC455_05554 | 54 | 1.12 | Mlig455_062512 | Neo: - Age: - |
0.969 | 0.969 | - | - | - | - | - | Mlig455_062512 {REF} {Length: 1169} {RNA1310_55738} {RNA815_31370.1} | |
62. | MligTC455_34728 | 30 | 0.63 | Mlig455_053077 | Neo: - Age: - |
GLIPR1 | 0.969 | - | - | - | - | - | 0.969 | Mlig455_053077 {REF} {Length: 3064} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=66.5]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [RH, Score=99.0, Expect=2e-22]} {Mouse: ENSMUSG00000056888, Glipr1, GLI pathogenesis-related 1 (glioma), [RH, Score=107, Expect=6e-26]} {Dmel: FBgn0038126, CG8483, [Score=53.1, Expect=4e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=67.0, Expect=6e-12]} {Smed: dd_Smed_v6_681_0_1, dd_Smed_v6_681_0_1, [Score=104, Expect=1e-25]} {RNA1310_23199} {RNA815_7031} |
63. | MligTC455_38600 | 71 | 1.49 | Mlig455_028052 | Neo: - Age: - |
CCDC87 | 0.969 | - | - | 0.969 | - | - | - | Mlig455_028052 {REF} {Length: 4672} {Pfam: Microtubule associated protein (MAP65/ASE1 family) [PF03999.14, score=22.6]} {Human: ENSG00000182791, CCDC87, coiled-coil domain containing 87, [RH, Score=116, Expect=8e-26]} {Mouse: ENSMUSG00000067872, Ccdc87, coiled-coil domain containing 87, [RH, Score=112, Expect=1e-24]} {Smed: dd_Smed_v6_12480_0_1, dd_Smed_v6_12480_0_1, [RH, Score=326, Expect=5e-96]} {RNA1509_8830} {RNA1310_2448.2, RNA1509_8830} {RNA1509_8830, RNA815_4309} |
64. | MligTC455_56513 | 8 | 0.16 | Mlig455_010760 | Neo: - Age: - |
0.968 | - | - | - | - | - | 0.968 | Mlig455_010760 {REF} {Length: 154} {NoTransDecoderORF} | |
65. | MligTC455_11926 | 101 | 2.11 | Mlig455_021319 | Neo: - Age: - Region-enriched R7: 4.905/0.00107 |
0.967 | 0.967 | - | - | - | - | - | Mlig455_021319 {REF} {Length: 2758} {Pfam: Mab-21 protein [PF03281.16, score=23.9]} {RNA1509_41055} {RNA1310_11481.1} {RNA815_44675} | |
66. | MligTC455_35051 | 220 | 4.58 | Mlig455_020175 | Neo: - Age: Down-Up-Down Region-enriched R8: 5.304/0.00000 |
CALM3 | 0.967 | 0.967 | - | - | - | - | - | Mlig455_020175 {REF} {Length: 927} {Pfam: EF hand [PF00036.34, score=111.3]; EF-hand domain pair [PF13499.8, score=98.6]; EF-hand domain [PF13405.8, score=91.1]; EF-hand domain pair [PF13833.8, score=78.1]; EF hand [PF13202.8, score=76.7]; EF-hand domain [PF14658.8, score=56.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=26.7]; Dockerin type I domain [PF00404.20, score=22.0]; EF-hand domain [PF17959.3, score=21.1]} {Human: ENSG00000160014, CALM3, calmodulin 3, [Score=146, Expect=5e-45]; ENSG00000198668, CALM1, calmodulin 1, [Score=146, Expect=5e-45]; ENSG00000143933, CALM2, calmodulin 2, [Score=146, Expect=5e-45]; ENSG00000178363, CALML3, calmodulin like 3, [Score=143, Expect=8e-44]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=146, Expect=3e-45]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=146, Expect=3e-45]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=146, Expect=3e-45]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=144, Expect=4e-44]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=148, Expect=8e-46]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=147, Expect=7e-46]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=147, Expect=5e-46]} {RNA1310_46966} {RNA815_26674} |
67. | MligTC455_14580 | 159 | 3.32 | Mlig455_030626, Mlig455_030698, Mlig455_031017 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 3.469/0.03212 |
0.965 | - | - | 0.965 | - | - | - | Mlig455_030626 {REF} {Length: 2569} {RNA1509_58943} {RNA1310_27039, RNA1509_58943} {RNA1509_58943, RNA815_16088} Mlig455_030698 {REF} {Length: 907} {RNA1509_39929} {RNA1310_27230} {RNA815_16088} Mlig455_031017 {REF} {Length: 1218} {RNA1509_39929} {RNA1310_27230} {RNA815_16088} |
|
68. | MligTC455_03020 | 77 | 1.61 | Mlig455_031009 | Neo: - Age: - |
PCDH7 | 0.964 | - | - | - | - | - | 0.964 | Mlig455_031009 {REF} {Length: 4201} {Pfam: Cadherin domain [PF00028.19, score=251.4]} {Human: ENSG00000169851, PCDH7, protocadherin 7, [Score=236, Expect=2e-63]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=263, Expect=2e-72]} {Dmel: FBgn0284247, ds, dachsous, [Score=207, Expect=1e-53]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=172, Expect=3e-43]} {Smed: dd_Smed_v6_17019_0_1, dd_Smed_v6_17019_0_1, [Score=290, Expect=8e-83]} {RNA1509_5672} {RNA1310_47266} {RNA815_2173} |
69. | MligTC455_09829 | 23 | 0.49 | Mlig455_020089 | Neo: - Age: Down-Up-Down |
0.964 | - | - | - | - | - | 0.964 | Mlig455_020089 {REF} {Length: 2399} {TRANSSPLICED} {RNA1310_22138} {RNA815_46507} | |
70. | MligTC455_11950 | 44 | 0.92 | Mlig455_027513 | Neo: - Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_027513 {REF} {Length: 414} {NoTransDecoderORF} {RNA1310_76126} {RNA815_15778.1} | |
71. | MligTC455_50028 | 97 | 2.02 | Mlig455_010934, Mlig455_033151 | Neo: - Age: - |
NPY1R | 0.962 | - | - | - | - | - | 0.962 | Mlig455_010934 {REF} {Length: 1960} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=110.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=34.7]; Srg family chemoreceptor [PF02118.23, score=21.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=92.8, Expect=8e-20]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=96.3, Expect=5e-21]; ENSMUSG00000038071, Npy6r, neuropeptide Y receptor Y6, [Score=92.4, Expect=6e-20]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=127, Expect=3e-31]} {Celegans: WBGene00008278, npr-10, NeuroPeptide Receptor family, [Score=95.9, Expect=2e-21]} {Smed: dd_Smed_v6_26109_0_1, dd_Smed_v6_26109_0_1, [Score=194, Expect=4e-55]} {RNA1310_25270} {RNA815_10045} Mlig455_033151 {REF} {Length: 1927} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=110.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=34.7]; Srg family chemoreceptor [PF02118.23, score=21.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=92.8, Expect=9e-20]} {Mouse: ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=96.7, Expect=5e-21]; ENSMUSG00000038071, Npy6r, neuropeptide Y receptor Y6, [Score=92.4, Expect=7e-20]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=127, Expect=3e-31]} {Celegans: WBGene00008278, npr-10, NeuroPeptide Receptor family, [Score=95.5, Expect=3e-21]} {Smed: dd_Smed_v6_26109_0_1, dd_Smed_v6_26109_0_1, [Score=195, Expect=3e-55]} {RNA1310_25270} {RNA815_10045} |
72. | MligTC455_10064 | 68 | 1.41 | Mlig455_029458, Mlig455_029482 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_029458 {REF} {Length: 1576} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=28.7]} {RNA1310_20120.1} {RNA815_50604} Mlig455_029482 {REF} {Length: 3696} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=29.0]} {RNA1310_20120.1} {RNA815_30795} |
|
73. | MligTC455_14294 | 37 | 0.78 | Mlig455_045370 | Neo: - Age: - |
PCDH1 | 0.96 | - | - | - | - | - | 0.960 | Mlig455_045370 {REF} {Length: 4947} {Pfam: Cadherin domain [PF00028.19, score=241.5]; Cadherin-like [PF08266.14, score=35.4]} {Human: ENSG00000156453, PCDH1, protocadherin 1, [Score=237, Expect=3e-63]} {Mouse: ENSMUSG00000051375, Pcdh1, protocadherin 1, [Score=239, Expect=1e-64]} {Dmel: FBgn0284247, ds, dachsous, [Score=203, Expect=2e-52]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=154, Expect=1e-37]} {Smed: dd_Smed_v6_21207_0_1, dd_Smed_v6_21207_0_1, [Score=263, Expect=7e-73]} {RNA1509_45430} {RNA1310_20787, RNA1509_45430} {RNA1509_45430, RNA815_48081} |
74. | MligTC455_07196 | 45 | 0.94 | Mlig455_026349 | Neo: - Age: - |
0.959 | - | - | - | - | - | 0.959 | Mlig455_026349 {REF} {Length: 350} {NoTransDecoderORF} {RNA1310_37227.1} {RNA815_56935} | |
75. | MligTC455_21984 | 305 | 6.35 | Mlig455_024350 | Neo: - Age: - |
NT5E | 0.959 | - | - | 0.959 | - | - | - | Mlig455_024350 {REF} {Length: 2710} {Pfam: 5'-nucleotidase, C-terminal domain [PF02872.20, score=110.3]; Calcineurin-like phosphoesterase [PF00149.30, score=42.5]} {Human: ENSG00000135318, NT5E, 5'-nucleotidase ecto, [RH, Score=103, Expect=8e-23]} {Mouse: ENSMUSG00000021718, 4933425L06Rik, RIKEN cDNA 4933425L06 gene, [RH, Score=383, Expect=4e-126]} {Dmel: FBgn0033538, CG11883, [RH, Score=461, Expect=2e-154]} {Smed: dd_Smed_v6_3474_0_1, dd_Smed_v6_3474_0_1, [RH, Score=464, Expect=1e-158]} {RNA1509_22709} {RNA1310_12561} {RNA815_22779} |
76. | MligTC455_24548 | 39 | 0.8 | Mlig455_031981 | Neo: - Age: - |
ROBO1 | 0.959 | - | - | - | - | - | 0.959 | Mlig455_031981 {REF} {Length: 4163} {Pfam: Immunoglobulin domain [PF13927.8, score=128.2]; Immunoglobulin I-set domain [PF07679.18, score=115.2]; Immunoglobulin domain [PF00047.27, score=78.6]; Immunoglobulin V-set domain [PF07686.19, score=73.6]; Immunoglobulin domain [PF13895.8, score=71.9]; Fibronectin type III domain [PF00041.23, score=22.4]} {Human: ENSG00000169855, ROBO1, roundabout guidance receptor 1, [Score=164, Expect=3e-40]} {Mouse: ENSMUSG00000032128, Robo3, roundabout guidance receptor 3, [Score=133, Expect=6e-31]} {Dmel: FBgn0005631, robo1, roundabout 1, [Score=139, Expect=4e-33]} {Celegans: WBGene00004729, sax-3, [Score=132, Expect=6e-31]} {Smed: dd_Smed_v6_8494_0_1, dd_Smed_v6_8494_0_1, [Score=239, Expect=1e-64]} {RNA1310_122847} {RNA815_62158} |
77. | MligTC455_49843 | 70 | 1.46 | Mlig455_058264, Mlig455_058281, Mlig455_070786 | Neo: - Age: - |
CHRNA3, CHRNA7 | 0.959 | 0.959 | - | - | - | - | - | Mlig455_058264 {REF} {Length: 2377} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.7]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=224, Expect=4e-66]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=222, Expect=2e-65]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=216, Expect=2e-63]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=223, Expect=8e-66]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=220, Expect=8e-65]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=219, Expect=6e-65]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=213, Expect=4e-62]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=240, Expect=3e-72]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=229, Expect=7e-69]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=227, Expect=1e-67]} {RNA1310_31785} {RNA815_40862} Mlig455_058281 {REF} {Length: 2912} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=179.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.5]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=239, Expect=1e-71]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=238, Expect=4e-71]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=236, Expect=1e-70]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=231, Expect=2e-69]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=229, Expect=4e-68]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=240, Expect=3e-72]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=232, Expect=3e-69]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=231, Expect=7e-69]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=228, Expect=3e-68]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=252, Expect=2e-76]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=250, Expect=1e-76]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=239, Expect=7e-72]} {RNA1310_31785} {RNA815_40862} Mlig455_070786 {REF} {Length: 1486} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=36.1]} {RNA1310_31785} {RNA815_43410} |
78. | MligTC455_48996 | 148 | 3.09 | Mlig455_000709, Mlig455_000763, Mlig455_033466 | Neo: - |
ANK2, CHRNB3 | 0.958 | - | - | 0.958 | - | - | - | Mlig455_000709 {REF} {Length: 4279} {TRANSSPLICED} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=216.3]; Ankyrin repeats (many copies) [PF13637.8, score=213.5]; Ankyrin repeats (many copies) [PF13857.8, score=161.7]; Ankyrin repeat [PF00023.32, score=156.2]; Ankyrin repeat [PF13606.8, score=143.5]; Mab-21 protein [PF03281.16, score=29.5]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=200, Expect=2e-51]; ENSG00000151150, ANK3, ankyrin 3, [Score=194, Expect=2e-49]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=196, Expect=5e-50]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=193, Expect=2e-49]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=202, Expect=3e-52]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=204, Expect=3e-53]} {Smed: dd_Smed_v6_3523_0_1, dd_Smed_v6_3523_0_1, [Score=182, Expect=3e-46]} {RNA1509_42834} {RNA1310_5424.1, RNA1509_42834} {RNA1509_42834, RNA815_8238} Mlig455_000763 {REF} {Length: 4250} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=255.0]; Ankyrin repeats (many copies) [PF13637.8, score=219.3]; Ankyrin repeat [PF00023.32, score=163.4]; Ankyrin repeat [PF13606.8, score=156.1]; Ankyrin repeats (many copies) [PF13857.8, score=150.4]; Mab-21 protein [PF03281.16, score=31.6]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=207, Expect=1e-53]; ENSG00000151150, ANK3, ankyrin 3, [Score=200, Expect=3e-51]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=202, Expect=6e-52]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=196, Expect=4e-50]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=209, Expect=2e-54]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=210, Expect=7e-55]} {Smed: dd_Smed_v6_6898_0_1, dd_Smed_v6_6898_0_1, [Score=180, Expect=1e-46]} {RNA1509_42834} {RNA1310_5424.1} {RNA815_8238} Mlig455_033466 {REF} {Length: 1168} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=104.2]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=32.8]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=114, Expect=1e-27]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=108, Expect=2e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=106, Expect=6e-25]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=94.0, Expect=1e-20]} {Celegans: WBGene00000951, deg-3, Acetylcholine receptor subunit alpha-type deg-3, [Score=96.7, Expect=2e-21]} {Smed: dd_Smed_v6_62726_0_1, dd_Smed_v6_62726_0_1, [Score=156, Expect=7e-44]} {RNA1310_44183.2} {RNA815_32188} |
79. | MligTC455_13751 | 141 | 2.93 | Mlig455_066278 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.685 Region-enriched R7: 3.016/0.04041 |
0.957 | 0.957 | - | - | - | - | - | Mlig455_066278 {REF} {Length: 3312} {Pfam: Innexin [PF00876.20, score=292.3]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=75.9, Expect=1e-14]} {Celegans: WBGene00000488, che-7, Innexin, [Score=193, Expect=7e-55]} {Smed: dd_Smed_v6_15239_0_1, dd_Smed_v6_15239_0_1, [Score=273, Expect=1e-86]} {RNA1509_53271} {RNA1310_13768.1, RNA1509_53271} {RNA1509_53271, RNA815_19062} | |
80. | MligTC455_20654 | 41 | 0.86 | Mlig455_000707 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_000707 {REF} {Length: 842} {NoTransDecoderORF} {RNA1509_18723} {RNA1310_2938.1} {RNA815_36985} | |
81. | MligTC455_38657 | 292 | 6.08 | Mlig455_021581 | Neo: - Age: - |
CPLX1 | 0.956 | - | - | - | - | - | 0.956 | Mlig455_021581 {REF} {Length: 2085} {Pfam: Synaphin protein [PF05835.14, score=132.9]} {Human: ENSG00000168993, CPLX1, complexin 1, [Score=52.4, Expect=8e-09]; ENSG00000145920, CPLX2, complexin 2, [Score=50.8, Expect=1e-08]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=53.5, Expect=2e-09]} {Dmel: FBgn0041605, cpx, complexin, [RH, Score=90.1, Expect=1e-23]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [RH, Score=99.4, Expect=2e-27]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=94.4, Expect=2e-25]} {RNA1509_37151, RNA1509_38047} {RNA1310_51275, RNA1509_38047} {RNA1509_38047, RNA815_22799} |
82. | MligTC455_16001 | 122 | 2.55 | Mlig455_010422 | Neo: - Age: - Region-enriched R7: 2.453/0.01782 |
0.955 | - | - | - | - | - | 0.955 | Mlig455_010422 {REF} {Length: 3200} {Pfam: Domain of unknown function (DUF3827) [PF12877.9, score=33.0]} {RNA1310_5480} {RNA815_22680} | |
83. | MligTC455_16485 | 42 | 0.88 | Mlig455_004972 | Neo: - Age: - Region-enriched R4: 4.118/0.01651 |
0.955 | - | - | - | - | - | 0.955 | Mlig455_004972 {REF} {Length: 3466} {RNA1509_19863} {RNA1310_10105.1} {RNA815_12791.1} | |
84. | MligTC455_45731 | 76 | 1.59 | Mlig455_003947, Mlig455_003964, Mlig455_005981 | Neo: - Age: Up-Down-Down |
TTLL7 | 0.955 | - | 0.955 | - | - | - | - | Mlig455_003947 {REF} {Length: 4060} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=212.9]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.9]; YheC/D like ATP-grasp [PF14398.8, score=21.3]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=351, Expect=4e-107]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=347, Expect=1e-103]} {Dmel: FBgn0039501, CG5987, [Score=235, Expect=3e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=158, Expect=4e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=313, Expect=3e-91]} {RNA1310_17573} {RNA815_57268} Mlig455_003964 {REF} {Length: 3783} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=213.2]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.9]; YheC/D like ATP-grasp [PF14398.8, score=21.3]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=353, Expect=2e-109]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=349, Expect=2e-104]} {Dmel: FBgn0039501, CG5987, [Score=234, Expect=4e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=157, Expect=7e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=312, Expect=4e-91]} {RNA1310_17573} {RNA815_57268} Mlig455_005981 {REF} {Length: 4222} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=213.3]; Sugar-transfer associated ATP-grasp [PF14397.8, score=23.7]; YheC/D like ATP-grasp [PF14398.8, score=21.1]} {Human: ENSG00000137941, TTLL7, tubulin tyrosine ligase like 7, [Score=353, Expect=2e-107]} {Mouse: ENSMUSG00000036745, Ttll7, tubulin tyrosine ligase-like family, member 7, [Score=349, Expect=9e-104]} {Dmel: FBgn0039501, CG5987, [Score=235, Expect=5e-65]} {Celegans: WBGene00019230, ttll-11, Tubulin Tyrosine Ligase Like, [Score=157, Expect=9e-40]} {Smed: dd_Smed_v6_13600_0_1, dd_Smed_v6_13600_0_1, [Score=314, Expect=3e-91]} {RNA1310_17573} {RNA815_57268} |
85. | MligTC455_12623 | 48 | 1 | Mlig455_065644 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_065644 {REF} {Length: 892} {NoTransDecoderORF} {RNA1310_95750} | |
86. | MligTC455_33157 | 281 | 5.86 | Mlig455_009092 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_009092 {REF} {Length: 5302} {RNA1509_51204} {RNA1310_20216} {RNA815_6624} | |
87. | MligTC455_39505 | 66 | 1.37 | Mlig455_030969 | Neo: - Age: - Region-enriched R2: 4.896/0.02013 |
0.954 | - | - | - | 0.954 | - | - | Mlig455_030969 {REF} {Length: 482} {NoTransDecoderORF} {RNA1509_9917} {RNA1310_4320.1} {RNA815_4192.2} | |
88. | MligTC455_53000 | 122 | 2.55 | Mlig455_017611 | Neo: - Age: Down-Up-Down |
0.954 | - | - | - | - | - | 0.954 | Mlig455_017611 {REF} {Length: 2577} {Pfam: Otopetrin [PF03189.15, score=21.6]} {RNA1509_54233} {RNA1310_9118} {RNA815_5019.1} | |
89. | MligTC455_00282 | 64 | 1.34 | Mlig455_011958 | Neo: - Age: - |
0.953 | - | - | - | - | - | 0.953 | Mlig455_011958 {REF} {Length: 258} {NoTransDecoderORF} | |
90. | MligTC455_20548 | 68 | 1.42 | Mlig455_051479 | Neo: - Age: logFC(26M/2M)=0.761 |
FEZF2 | 0.953 | - | - | 0.953 | - | - | - | Mlig455_051479 {REF} {Length: 1530} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=95.0]; C2H2-type zinc finger [PF13894.8, score=72.0]; Zinc-finger double domain [PF13465.8, score=66.9]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=25.8]} {Human: ENSG00000153266, FEZF2, FEZ family zinc finger 2, [Score=299, Expect=2e-98]; ENSG00000128610, FEZF1, FEZ family zinc finger 1, [Score=294, Expect=5e-97]} {Mouse: ENSMUSG00000021743, Fezf2, Fez family zinc finger 2, [Score=302, Expect=5e-100]; ENSMUSG00000029697, Fezf1, Fez family zinc finger 1, [Score=294, Expect=1e-96]} {Dmel: FBgn0031375, erm, earmuff, [Score=301, Expect=5e-98]} {Celegans: WBGene00012639, fezf-1, FEZ Family zinc finger protein, [RH, Score=278, Expect=9e-94]} {Smed: dd_Smed_v6_26394_0_1, dd_Smed_v6_26394_0_1, [Score=255, Expect=1e-84]} {RNA1310_19447} {RNA815_61285} |
91. | MligTC455_24825 | 105 | 2.19 | Mlig455_011292 | Neo: - Age: - |
0.953 | - | - | 0.953 | - | - | - | Mlig455_011292 {REF} {Length: 3653} {RNA1509_43125} {RNA1310_9297, RNA1509_43125} {RNA1509_43125, RNA815_39862} | |
92. | MligTC455_40260 | 7083 | 147.57 | Mlig455_058193 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.425 Region-enriched R7: 5.743/0.00000 Regeneration-depleted BL: -13.476 |
AVP | 0.953 | - | - | - | - | - | 0.953 | Mlig455_058193 {REF} {Length: 1929} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=58.6]} {Human: ENSG00000101200, AVP, arginine vasopressin, [RH, Score=58.5, Expect=2e-10]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [RH, Score=63.9, Expect=2e-12]} {RNA1509_15970} {RNA1310_46866} {RNA815_23759} |
93. | MligTC455_25852 | 257 | 5.35 | Mlig455_026376 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.913/0.04400 |
0.95 | 0.950 | - | - | - | - | - | Mlig455_026376 {REF} {Length: 1440} {Pfam: PLAC8 family [PF04749.19, score=60.9]} {Smed: dd_Smed_v6_865_0_1, dd_Smed_v6_865_0_1, [Score=98.2, Expect=1e-26]} {RNA1509_36976} {RNA1310_18646} {RNA815_10637.1} |